Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.
about
Differential activation of peritoneal cells by subcutaneous treatment of rats with cryptococcal antigensCryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan.Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphoryl lipid AAntigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformansCTLA-4 down-regulates the protective anticryptococcal cell-mediated immune responseDifferences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformansEffects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune responseIntravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.A Cryptosporidium parvum genomic region encoding hemolytic activity.Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis.Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host responseWhat makes Cryptococcus neoformans a pathogen?
P2860
Q28573435-7DD750E3-4F5D-4481-BF36-4E792F78059EQ30424017-FBC7714F-9F77-4A56-A6E7-C748594375EBQ33752145-686B2975-727A-40E0-BBA2-C2207DE62470Q33752157-C04A5E5B-B174-47D7-999B-91748754949DQ33754495-58269E71-AF22-43F4-B89D-749BE9FEC979Q34007765-DCAD909F-F548-44C4-89F5-17933548DFA3Q34118259-42D9E171-5195-477B-96CC-C4C12C3C1267Q34530189-4D6073EF-96F0-4660-B8A7-27BE70C494ADQ35390183-9491D3A7-D78C-4AD5-95A6-335AABB24A00Q35441816-AB02E2F8-0405-4E4D-9A5C-A74B410B7782Q35781421-4B696C00-1326-47D2-96B8-E30DBD5C45B7Q36845205-84867D4F-C16D-4FFE-A015-699C5A0FCB7BQ41695186-353210BF-6D88-47DF-8754-1C8869A02E3F
P2860
Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Regulation of cytokine product ...... ype hypersensitivity response.
@ast
Regulation of cytokine product ...... ype hypersensitivity response.
@en
Regulation of cytokine product ...... ype hypersensitivity response.
@nl
type
label
Regulation of cytokine product ...... ype hypersensitivity response.
@ast
Regulation of cytokine product ...... ype hypersensitivity response.
@en
Regulation of cytokine product ...... ype hypersensitivity response.
@nl
prefLabel
Regulation of cytokine product ...... ype hypersensitivity response.
@ast
Regulation of cytokine product ...... ype hypersensitivity response.
@en
Regulation of cytokine product ...... ype hypersensitivity response.
@nl
P2860
P1476
Regulation of cytokine product ...... ype hypersensitivity response.
@en
P2093
J W Murphy
K L Buchanan
P2860
P304
P407
P577
1994-07-01T00:00:00Z